Search form
Search
contact us
Navigation
home
boards
Jobs
job ratings
cp wire
medtech news
pharmagather
catering
advertise
whistleblower info
pharmaceutical fraud
medical device | DME fraud
clinical lab fraud
False Claims Act
Legal Help
login/register
You are here
Home
»
companies
» Sotyktu
Sotyktu
Alumis readies IPO to fund rival drug to Bristol Myers’ Sotyktu
BioPharma Dive
Mon, 06/10/24 - 11:17 am
Alumis
IPOs
funding
Bristol Myers Squibb
Sotyktu
psoriatic arthritis
BMS reports four-year data from psoriasis treatment extension trial
Clinical Trials Arena
Fri, 05/17/24 - 11:14 am
Bristol Myers Squibb
Sotyktu
clinical trials
psoriasis
Bristol Myers says it needs another year to hit target for new drugs
Reuters
Thu, 10/26/23 - 10:40 am
Bristol Myers Squibb
Reblozyl
Sotyktu
Zeposia
BMS’ Sotyktu cleared for NHS use in psoriasis
Pharmaphorum
Thu, 06/29/23 - 11:33 am
Bristol Myers Squibb
Sotyktu
psoriasis
NHS
UK
Nimbus on cloud 9 as psoriasis data support taking rival to Bristol Myers' Sotyktu into phase 3
Fierce Biotech
Wed, 11/30/22 - 10:38 am
Nimbus Therapeutics
Sotyktu
Bristol Myers Squibb
clinical trials
NDI-034858
Nimbus hopes to best Bristol’s Sotyktu
EP Vantage
Fri, 11/4/22 - 10:15 am
Bristol Myers Squibb
Sotyktu
Nimbus
NDI-034858
psoriasis
Nimbus raises $125M to advance rival to Bristol Myers’ new psoriasis drug
BioPharma Dive
Mon, 09/12/22 - 11:39 pm
Nimbus Therapeutics
psoriasis
Bristol Myers Squibb
Sotyktu
Bristol Myers gets FDA approval for new type of psoriasis drug
BioPharma Dive
Sun, 09/11/22 - 11:09 pm
Bristol Myers Squibb
Sotyktu
FDA
psoriasis